Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-018228
Filing Date
2019-06-26
Accepted
2019-06-26 19:34:11
Documents
2
Period of Report
2019-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1500
2 EX-24 DOCUMENT attachment1.htm EX-24 4341
  Complete submission text file 0000899243-19-018228.txt   7218
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
Parschauer Karah Herdman (Reporting) CIK: 0001677455 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38942 | Film No.: 19922782

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations